MedTrace Logo

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

NCT06417710 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-05-16

No results posted yet for this study

Summary

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Conditions

  • Leptomeningeal Metastasis
  • Leptomeningeal Disease
  • Leptomeningeal Neoplasms
  • Leptomeningeal Cancer

Interventions

OTHER

Neurological Assessment

Clinical neurological assessment performed by 2 raters

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • The Netherlands Cancer Institute

    collaborator OTHER

  • University of Zurich

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-30
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06417710 on ClinicalTrials.gov